Laura Maté

Laura Maté

Auto-generated profile, based on publicly available information

Laura Maté

Centro de Investigación Veterinaria de Tandil (CIVETAN), UNCPBA ‐ Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) ‐ Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CICPBA) Tandil, Buenos Aires Argentina

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Veterinary Parasitology
Verified
Journal Article
Closed access
LMLaura Mate
Laura Mate
MBMariana Ballent
Mariana Ballent
CCCandela Canton
Candela Canton
CLCarlos Lanusse
Carlos Lanusse
LCLaura Ceballos
Laura Ceballos
JLJuan Pedro Liron
Juan Pedro Liron

19 November 2015 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Open access
LTLaura Moreno Torrejon
Laura Moreno Torrejon
PRPaula Revenga-Domínguez
Paula Revenga-Domínguez
CFCristina Farias
Cristina Farias
LCLucila Canton
Lucila Canton
GVGuillermo Virkel
Guillermo Virkel
LALuis Alvarez
Luis Alvarez
The goals were to determine the ivermectin (IVM) plasma pharmacokinetics, tissue and egg residue profiles, and in vitro metabolism in laying hens. Experiments conducted were (1) 8 hens were intravenously treated with IVM and blood samples taken; (2) 88 hens were treated with IVM administered daily in water (5 days) (40 were kept and their daily eggs collected; 48 were sacrificed in groups (n = 8) at different times and tissue samples taken and analyzed); (3) IVM biotransformation was studied in liver microsomes. Pharmacokinetic parameters were AUC = 85.1 ng·day/mL, Vdss = 4.43 L/kg, and T1/2el = 1.73 days. Low IVM tissue residues were quantified with the highest measured in liver and skin+fat. IVM residues were not found in egg white, but significant amounts were quantified in yolk. Residues measured in eggs were greater than some MRL values, suggesting that a withdrawal period would be necessary for eggs after IVM use in laying hens.

1 May 2015 in Veterinary Parasitology
Verified
Journal Article
Open access
LALuis Alvarez
Luis Alvarez
GSGonzalo Suárez
Gonzalo Suárez
LCLaura Ceballos
Laura Ceballos
LTLaura Moreno Torrejon
Laura Moreno Torrejon
CCCandela Canton
Candela Canton
CLCarlos Lanusse
Carlos Lanusse
The main goals of the current work were: (a) to assess the ivermectin (IVM) systemic exposure and plasma disposition kinetics after its administration at the recommended dose, x5 and x10 doses to lambs, (b) to compare the clinical efficacy of the same IVM dosages in lambs infected with an IVM-resistant isolate of Haemonchus contortus, and (c) to assess the expression of the transporter protein P-glycoprotein (P-gp) in H. contortus recovered at 14 days after administration of the IVM dose regimens. There were two separated trials where IVM was administered either subcutaneously (SC, Experiment I) or intraruminally (IR, Experiment II). Each experiment involved twenty-four (24) lambs artificially infected with a highly resistant H. contortus isolate. Animals were allocated into 4 groups (n=6) and treated with IVM at either 0.2 (IVM x1), 1 (IVM x5) or 2mg/kg (IVM x10). Plasma samples were collected up to 12 days post-treatment and analysed by HPLC. An untreated-control Group was included to assess the comparative anthelmintic efficacy of the different treatments. The level of expression of Pgp in H. contortus specimens obtained from lambs both untreated and IR treated with the different IVM doses was quantified by real time PCR. Parametric and non-parametric tests were used to compare the statistical significance of the results (P<0.05). After the SC treatment, the IVM plasma area under the concentration-time curve (AUC0-LOQ) increased from 41.9 (IVM SCx1) up to 221 (IVM SCx5) and 287 (IVM SCx10)ng.day/mL and after the IR treatment from 20.8 (IVM IRx1) up to 121 (IVM IRx5) and 323 (IVM IRx10)ng.day/mL. Dose-adjusted AUC0-LOQ and Cmax were similar among doses, demonstrating dose proportionality for IVM after both SC and IR administration at the three different doses. The efficacies against resistant H. contortus after the SC treatment were 42% (IVM SC1), 75% (IVM SCx5) and 75% (IVM SCx10). However, the IR IVM treatment reached clinical efficacies ranging from 48% (IVM IRx1) up to 96% (IVM IRx5) and 98% (IVM IRx10). None of the IR IVM treatments increased the expression of P-gp in adult H. contortus at 14 days post-treatment compared to samples collected from the untreated control group. An enhanced parasite exposure of the drug at the abomasum may explain the improved efficacy against this recalcitrant H. contortus isolate observed only after the IR administration at 5- and 10-fold the IVM therapeutic dosage.

27 August 2026 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
SMS. Martínez
S. Martínez
MSM. J. Del Sole
M. J. Del Sole
LML. Maté
L. Maté
SBSergio Fabian Sanchez Bruni
Sergio Fabian Sanchez Bruni
ALA. Lifschitz
A. Lifschitz
MBM. Ballent
M. Ballent